Download PDF
Semin Respir Crit Care Med 2013; 34(01): 143-150
DOI: 10.1055/s-0033-1333576
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Management of Extrapulmonary Nontuberculous Mycobacterial Infections

Shannon Kasperbauer
1   Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, Colorado
2   Division of Infectious Diseases, University of Colorado Health Sciences Center, Aurora, Colorado
,
Gwen Huitt
1   Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, Colorado
2   Division of Infectious Diseases, University of Colorado Health Sciences Center, Aurora, Colorado
› Author Affiliations
Further Information

Publication History

Publication Date:
04 March 2013 (online)

    Permissions and Reprints

Abstract

Nontuberculous mycobacteria represent a vast group of environmental organisms that have the potential to cause disease in humans. Unlike tuberculosis, these organisms are not known to be transmitted from human to human. The most common clinical presentation is pulmonary disease. Approximately 10% of infections manifest as extrapulmonary disease. The portals of entry are the respiratory tract, gastrointestinal tract, or direct inoculation via trauma or an invasive procedure. Like tuberculosis, the nontuberculous mycobacteria have the potential to infect any organ system given the opportunity in an immunocompromised host. The spectrum of disease is extensive ranging from self-limited furunculosis to life-threatening disseminated infection. Common extrapulmonary manifestations include lymphadenitis, disseminated disease, skin, soft tissue, and bone infection. Less common manifestations include keratitis, catheter-related bloodstream infections, septic arthritis, central nervous system infection, and peritonitis. The incidence of extrapulmonary infections is unknown. Outbreaks have been reported due to inadequate disinfection of surgical equipment or contamination of injected solutions or medications. A high index of suspicion is required when patients present with subacute or chronic complaints of extrapulmonary infection. This review addresses the management of the common extrapulmonary nontuberculous infections.

Keywords

nontuberculous mycobacteria - extrapulmonary infection - disseminated infection
 

  • References

  • 1 Griffith DE, Aksamit T, Brown-Elliott BA , et al; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175 (4) 367-416
    CrossrefPubMedGoogle Scholar
  • 2 Haverkamp MH, Lindeboom JA, de Visser AW , et al. Nontuberculous mycobacterial cervicofacial lymphadenitis in children from the multicenter, randomized, controlled trial in The Netherlands: relevance of polymorphisms in candidate host immunity genes. Int J Pediatr Otorhinolaryngol 2010; 74 (7) 752-754
    CrossrefPubMedGoogle Scholar
  • 3 Blyth CC, Best EJ, Jones CA , et al. Nontuberculous mycobacterial infection in children: a prospective national study. Pediatr Infect Dis J 2009; 28 (9) 801-805
    CrossrefPubMedGoogle Scholar
  • 4 Ding LW, Lai CC, Lee LN, Huang LM, Hsueh PR. Lymphadenitis caused by non-tuberculous mycobacteria in a university hospital in Taiwan: predominance of rapidly growing mycobacteria and high recurrence rate. J Formos Med Assoc 2005; 104 (12) 897-904
    PubMedGoogle Scholar
  • 5 Schaad UB, Votteler TP, McCracken Jr GH, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr 1979; 95 (3) 356-360
    CrossrefPubMedGoogle Scholar
  • 6 Fraser L, Moore P, Kubba H. Atypical mycobacterial infection of the head and neck in children: a 5-year retrospective review. Otolaryngol Head Neck Surg 2008; 138: 311-314
    CrossrefPubMedGoogle Scholar
  • 7 Iversen RH, Illum P. Cervicofacial nontuberculous mycobacterial lymphadenitis in children. Dan Med J 2012; 59 (1) A4349
    Google Scholar
  • 8 Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES, Lindeboom R, Prins JM. Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis 2007; 44 (8) 1057-1064
    Google Scholar
  • 9 Lindeboom JA. Surgical treatment for nontuberculous mycobacterial (NTM) cervicofacial lymphadenitis in children. J Oral Maxillofac Surg 2012; 70 (2) 345-348
    CrossrefPubMedGoogle Scholar
  • 10 Harris RL, Modayil P, Adam J , et al. Cervicofacial nontuberculous mycobacterium lymphadenitis in children: is surgery always necessary?. Int J Pediatr Otorhinolaryngol 2009; 73 (9) 1297-1301
    Google Scholar
  • 11 Luong A, McClay JE, Jafri HS, Brown O. Antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis. Laryngoscope 2005; 115 (10) 1746-1751
    CrossrefPubMedGoogle Scholar
  • 12 Hazra R, Robson CD, Perez-Atayde AR, Husson RN. Lymphadenitis due to nontuberculous mycobacteria in children: presentation and response to therapy. Clin Infect Dis 1999; 28 (1) 123-129
    CrossrefPubMedGoogle Scholar
  • 13 Losurdo G, Castagnola E, Cristina E , et al. Cervical lymphadenitis caused by nontuberculous mycobacteria in immunocompetent children: clinical and therapeutic experience. Head Neck 1998; 20 (3) 245-249
    CrossrefPubMedGoogle Scholar
  • 14 Berger C, Pfyffer GE, Nadal D. Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. J Pediatr 1996; 128 (3) 383-386
    PubMedGoogle Scholar
  • 15 Zeharia A, Eidlitz-Markus T, Haimi-Cohen Y, Samra Z, Kaufman L, Amir J. Management of nontuberculous mycobacteria-induced cervical lymphadenitis with observation alone. Pediatr Infect Dis J 2008; 27 (10) 920-922
    Google Scholar
  • 16 Lindeboom JA. Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis 2011; 52 (2) 180-184
    CrossrefPubMedGoogle Scholar
  • 17 Penn R, Steehler MK, Sokohl A, Harley EH. Nontuberculous mycobacterial cervicofacial lymphadenitis—a review and proposed classification system. Int J Pediatr Otorhinolaryngol 2011; 75 (12) 1599-1603
    CrossrefPubMedGoogle Scholar
  • 18 Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005; 5 (6) 361-373
    CrossrefPubMedGoogle Scholar
  • 19 Phillips P, Bonner S, Gataric N , et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 2005; 41 (10) 1483-1497
    CrossrefPubMedGoogle Scholar
  • 20 McAllister WA, Thompson PJ, Al-Habet SM, Rogers HJ. Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 1983; 286 (6369) 923-925
    CrossrefPubMedGoogle Scholar
  • 21 Carrie F, Roblot P, Bouquet S, Delon A, Roblot F, Becq-Giraudon B. Rifampin-induced nonresponsiveness of giant cell arteritis to prednisone treatment. Arch Intern Med 1994; 154 (13) 1521-1524
    CrossrefPubMedGoogle Scholar
  • 22 Bark CM, Traboulsi RS, Honda K, Starnes AM, Jacobs MR, Rodriguez B. Disseminated Mycobacterium chelonae infection in a patient receiving an epidermal growth factor receptor inhibitor for advanced head and neck cancer. J Clin Microbiol 2012; 50 (1) 194-195
    CrossrefPubMedGoogle Scholar
  • 23 Forslund T, Rummukainen M, Kousa M, Krees R, Relander A, Katila ML. Disseminated cutaneous infection due to Mycobacterium chelonae in a patient with rheumatoid arthritis, amyloidosis, and renal failure. Nephrol Dial Transplant 1995; 10 (7) 1234-1236
    PubMedGoogle Scholar
  • 24 Chen CY, Sheng WH, Lai CC , et al. Mycobacterial infections in adult patients with hematological malignancy. Eur J Clin Microbiol Infect Dis 2012; 31 (6) 1059-1066
    CrossrefPubMedGoogle Scholar
  • 25 Lau SK, Curreem SO, Ngan AH, Yeung CK, Yuen KY, Woo PC. First report of disseminated Mycobacterium skin infections in two liver transplant recipients and rapid diagnosis by hsp65 gene sequencing. J Clin Microbiol 2011; 49 (11) 3733-3738
    CrossrefPubMedGoogle Scholar
  • 26 Garrison AP, Morris MI, Doblecki Lewis S , et al. Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature. Transpl Infect Dis 2009; 11 (6) 541-548
    CrossrefPubMedGoogle Scholar
  • 27 Doucette K, Fishman JA. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004; 38 (10) 1428-1439
    CrossrefPubMedGoogle Scholar
  • 28 Streit M, Böhlen LM, Hunziker T , et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol 2006; 16 (1) 79-83
    PubMedGoogle Scholar
  • 29 MacGregor RR, Hafner R, Wu JW , et al; ACTG Protocol 341 Team. Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study. AIDS Res Hum Retroviruses 2005; 21 (8) 689-695
    CrossrefPubMedGoogle Scholar
  • 30 Chaisson RE, Benson CA, Dube MP , et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: a randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Ann Intern Med 1994; 121 (12) 905-911
    CrossrefPubMedGoogle Scholar
  • 31 Gordin FM, Sullam PM, Shafran SD , et al. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. Clin Infect Dis 1999; 28 (5) 1080-1085
    CrossrefPubMedGoogle Scholar
  • 32 Benson CA, Williams PL, Currier JS , et al; AIDS Clinical Trials Group 223 Protocol Team. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis 2003; 37 (9) 1234-1243
    CrossrefPubMedGoogle Scholar
  • 33 Masur H, Kaplan JE, Holmes KK, Service USPH. U.S. Public Health Service; Infectious Diseases Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons—2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 2002; 137 (5 Pt 2) 435-478
    CrossrefPubMedGoogle Scholar
  • 34 Horsburgh Jr CR, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1989; 139 (1) 4-7
    CrossrefPubMedGoogle Scholar
  • 35 Adhikesavan LG, Harrington TM. Local and disseminated infections caused by Mycobacterium marinum: an unusual cause of subcutaneous nodules. J Clin Rheumatol 2008; 14 (3) 156-160
    CrossrefPubMedGoogle Scholar
  • 36 Cooper JF, Lichtenstein MJ, Graham BS, Schaffner W. Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients. Am J Med 1989; 86 (2) 173-177
    CrossrefPubMedGoogle Scholar
  • 37 Czelusta A, Moore AY. Cutaneous Mycobacterium kansasii infection in a patient with systemic lupus erythematosus: case report and review. J Am Acad Dermatol 1999; 40 (2 Pt 2) 359-363
    CrossrefPubMedGoogle Scholar
  • 38 Chetchotisakd P, Mootsikapun P, Anunnatsiri S , et al. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin Infect Dis 2000; 30 (1) 29-34
    CrossrefPubMedGoogle Scholar
  • 39 Morales P, Gil A, Santos M. Mycobacterium abscessus infection in transplant recipients. Transplant Proc 2010; 42 (8) 3058-3060
    CrossrefPubMedGoogle Scholar
  • 40 Bennett C, Vardiman J, Golomb H. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med 1986; 80 (5) 891-896
    CrossrefPubMedGoogle Scholar
  • 41 Green L, Coumbe A, Sawicka E, De Lord C. Mycobacterium kansasii in a patient with hairy cell leukaemia. Br J Haematol 2009; 144 (1) 2
    CrossrefPubMedGoogle Scholar
  • 42 Winthrop K, Baxter R, Liu L , et al. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis 2012;
    PubMedGoogle Scholar
  • 43 Uslan DZ, Jacobson KM, Kumar N, Berbari EF, Orenstein R. A woman with fever and rash after African safari. Clin Infect Dis 2006; 43 (5) 609 , 661–662
    CrossrefPubMedGoogle Scholar
  • 44 Wallace Jr RJ, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993; 119 (6) 482-486
    CrossrefPubMedGoogle Scholar
  • 45 Vemulapalli RK, Cantey JR, Steed LL, Knapp TL, Thielman NM. Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review. J Infect 2001; 43 (3) 163-168
    CrossrefPubMedGoogle Scholar
  • 46 Tebas P, Sultan F, Wallace Jr RJ, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis 1995; 20 (2) 443-444
    CrossrefPubMedGoogle Scholar
  • 47 Duarte RS, Lourenço MC, Fonseca LdeS , et al. Epidemic of postsurgical infections caused by Mycobacterium massiliense. J Clin Microbiol 2009; 47 (7) 2149-2155
    CrossrefPubMedGoogle Scholar
  • 48 Wertman R, Miller M, Groben P, Morrell DS, Culton DA. Mycobacterium bolletii/Mycobacterium massiliense furunculosis associated with pedicure footbaths: a report of 3 cases. Arch Dermatol 2011; 147 (4) 454-458
    CrossrefPubMedGoogle Scholar
  • 49 Stout JE, Gadkowski LB, Rath S, Alspaugh JA, Miller MB, Cox GM. Pedicure-associated rapidly growing mycobacterial infection: an endemic disease. Clin Infect Dis 2011; 53 (8) 787-792
    CrossrefPubMedGoogle Scholar
  • 50 Vugia DJ, Jang Y, Zizek C, Ely J, Winthrop KL, Desmond E. Mycobacteria in nail salon whirlpool footbaths, California. Emerg Infect Dis 2005; 11 (4) 616-618
    CrossrefPubMedGoogle Scholar
  • 51 Winthrop KL, Abrams M, Yakrus M , et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med 2002; 346 (18) 1366-1371
    CrossrefPubMedGoogle Scholar
  • 52 Nash KA, Zhang Y, Brown-Elliott BA, Wallace Jr RJ. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother 2005; 55 (2) 170-177
    CrossrefPubMedGoogle Scholar
  • 53 Cheung JP, Fung BK, Ip WY. Mycobacterium marinum infection of the deep structures of the hand and wrist: 25 years of experience. Hand Surg 2010; 15 (3) 211-216
    CrossrefPubMedGoogle Scholar
  • 54 Aubry A, Chosidow O, Caumes E, Robert J, Cambau E. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002; 162 (15) 1746-1752
    CrossrefPubMedGoogle Scholar
  • 55 Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37 (3) 390-397
    CrossrefPubMedGoogle Scholar
  • 56 Wiegell SR, Kongshoj B, Wulf HC. Mycobacterium marinum infection cured by photodynamic therapy. Arch Dermatol 2006; 142 (9) 1241-1242
    PubMedGoogle Scholar
  • 57 Hisamichi K, Hiruma M, Yamazaki M, Matsushita A, Ogawa H. Efficacy of oral minocycline and hyperthermic treatment in a case of atypical mycobacterial skin infection by Mycobacterium marinum. J Dermatol 2002; 29 (12) 810-811
    PubMedGoogle Scholar
  • 58 George KM, Chatterjee D, Gunawardana G , et al. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999; 283 (5403) 854-857
    CrossrefPubMedGoogle Scholar
  • 59 Adusumilli S, Mve-Obiang A, Sparer T, Meyers W, Hayman J, Small PL. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo. Cell Microbiol 2005; 7 (9) 1295-1304
    CrossrefPubMedGoogle Scholar
  • 60 Etuaful S, Carbonnelle B, Grosset J , et al. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 2005; 49 (8) 3182-3186
    CrossrefPubMedGoogle Scholar
  • 61 Sarfo FS, Phillips R, Asiedu K , et al. Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease. Antimicrob Agents Chemother 2010; 54 (9) 3678-3685
    CrossrefPubMedGoogle Scholar
  • 62 Nienhuis WA, Stienstra Y, Thompson WA , et al. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet 2010; 375 (9715) 664-672
    CrossrefPubMedGoogle Scholar
  • 63 Chauty A, Ardant MF, Marsollier L , et al. Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin. Clin Infect Dis 2011; 52 (1) 94-96
    CrossrefPubMedGoogle Scholar
  • 64 O'Brien DP, McDonald A, Callan P , et al. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. PLoS Negl Trop Dis 2012; 6 (1) e1473
    CrossrefPubMedGoogle Scholar
  • 65 John T, Velotta E. Nontuberculous (atypical) mycobacterial keratitis after LASIK: current status and clinical implications. Cornea 2005; 24 (3) 245-255
    CrossrefPubMedGoogle Scholar
  • 66 Chandra NS, Torres MF, Winthrop KL , et al. Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis. Am J Ophthalmol 2001; 132 (6) 819-830
    CrossrefPubMedGoogle Scholar
  • 67 Fulcher SF, Fader RC, Rosa Jr RH, Holmes GP. Delayed-onset mycobacterial keratitis after LASIK. Cornea 2002; 21 (6) 546-554
    CrossrefPubMedGoogle Scholar
  • 68 Holmes GP, Bond GB, Fader RC, Fulcher SF. A Cluster of cases of Mycobacterium szulgai keratitis that occurred after laser-assisted in situ keratomileusis. Clin Infect Dis 2002; 34 (8) 1039-1046
    CrossrefPubMedGoogle Scholar
  • 69 Winthrop KL, Steinberg EB, Holmes G , et al. Epidemic and sporadic cases of nontuberculous mycobacterial keratitis associated with laser in situ keratomileusis. Am J Ophthalmol 2003; 135 (2) 223-224
    CrossrefPubMedGoogle Scholar
  • 70 Chang MA, Jain S, Azar DT. Infections following laser in situ keratomileusis: an integration of the published literature. Surv Ophthalmol 2004; 49 (3) 269-280
    CrossrefPubMedGoogle Scholar
  • 71 Huang SC, Soong HK, Chang JS, Liang YS. Non-tuberculous mycobacterial keratitis: a study of 22 cases. Br J Ophthalmol 1996; 80 (11) 962-968
    CrossrefPubMedGoogle Scholar
  • 72 Bottone EJ, Cho KW. Mycobacterium chelonae keratitis: elucidation of diagnosis through evaluation of smears of fluid from patient's contact lens care system. Cornea 2005; 24 (3) 356-358
    CrossrefPubMedGoogle Scholar
  • 73 Malecha MA, Doughman DJ. Mycobacterium chelonae keratitis associated with soft contact lens wear. The CLAO journal: official publication of the Contact Lens Association of Ophthalmologists. Inc 2002; 28: 228-230
    PubMedGoogle Scholar
  • 74 Chang CY, Tsay RW, Lin LC, Liu CE. Venous catheter-associated bacteremia caused by rapidly growing mycobacteria at a medical center in central Taiwan. J Microbiol Immunol Infect 2009; 42 (4) 343-350
    PubMedGoogle Scholar
  • 75 Raad II, Vartivarian S, Khan A, Bodey GP. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991; 13 (6) 1120-1125
    CrossrefPubMedGoogle Scholar
  • 76 Hawkins C, Qi C, Warren J, Stosor V. Catheter-related bloodstream infections caused by rapidly growing nontuberculous mycobacteria: a case series including rare species. Diagn Microbiol Infect Dis 2008; 61 (2) 187-191
    CrossrefPubMedGoogle Scholar